在糖尿病MDR-TB患者中预测贝达基林治疗反应的多种生物标志物的整合
Liqing Zhu1, Mengmeng Li2, Zhongjian Wang1
1Department of Pharmacy, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210003, China.
概括
药物水平和糖尿病控制的整合预测了多药耐药结核病治疗的成功. 最佳的贝达基林暴露与良好的血糖控制相结合,对于患有MDR-TB的糖尿病患者至关重要.
科学领域:
- 药理动力学和药理动力学
- 传染性疾病 传染性疾病
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病复杂化了多抗药结核病 (MDR-TB) 的治疗.
- 预测糖尿病MDR-TB患者的治疗反应是具有挑战性的.
研究的目的:
- 研究结合贝达奎林的药理动力学,炎症标志物和血糖参数对糖尿病MDR-TB患者治疗反应的预测价值.
- 开发治疗成功的预测模型.
主要方法:
- 对186名糖尿病MDR-TB患者进行了回顾性队列研究,这些患者接受了含贝达基林的治疗方案.
- 测量了贝达基林的最低度,炎症标志物 (CRP,IL-6,TNF-α) 和血糖指数 (HbA1c,禁食葡萄糖).
- 使用多变量逻辑回归并开发了一个预测模型.
主要成果:
- 整体治疗响应率为72.0%.
- 更高的贝达基林度和更好的血糖控制与反应相关.
- 一个综合模型 (bedaquiline度,CRP,HbA1c) 的表现优于单个生物标志物.
- 低血糖控制否定了反应,即使在高贝达基林水平.
结论:
- 多种生物标志物集成有效预测糖尿病MDR-TB患者的贝达基林治疗反应.
- 适当的药物暴露和血糖控制是治疗成功的协同作用.
- 综合治疗药物监测和糖尿病管理至关重要.
相关概念视频
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182


